Neurostil (Gabapentin) Capsules: Comprehensive Information
What is Neurostil?
Neurostil is the brand name for gabapentin, an antiepileptic medication that is FDA-approved for managing postherpetic neuralgia in adults and as adjunctive therapy for partial onset seizures with or without secondary generalization in adults and children 3 years and older. 1
Composition and Mechanism
- Active ingredient: Gabapentin 1
- Inactive ingredients: Mannitol, hydroxypropyl cellulose, crospovidone, talc, magnesium stearate, and Aquarius® BP18114 Cool Vanilla 1
- Gabapentin is a structural analogue of GABA but has a mechanism of action distinct from GABA-related effects, though the exact mechanism remains incompletely understood 2, 3
- The drug penetrates the CNS despite being a GABA analogue that typically does not cross the blood-brain barrier 3
FDA-Approved Indications
- Management of postherpetic neuralgia in adults 1
- Adjunctive therapy for partial onset seizures (with and without secondary generalization) in adults and pediatric patients 3 years and older with epilepsy 1
Off-Label Uses (Evidence-Based)
- HIV-associated neuropathic pain: Gabapentin is recommended as first-line oral pharmacological treatment, titrated to a maximum of 2400 mg/day over 4 weeks 4
- Diabetic peripheral neuropathy: Effective at doses of 1800-3600 mg/day, with 38% of patients achieving at least 50% pain reduction versus 21% with placebo 5, 6
- Chronic neuropathic pain syndromes: Relieves allodynia, burning pain, shooting pain, and hyperesthesia 7
Dosing Guidelines
Standard Neuropathic Pain Dosing
Start gabapentin at 100-300 mg at bedtime on day 1, increase to 300 mg three times daily (900 mg/day) by day 3, then titrate upward by 300 mg every 3-7 days until reaching the target therapeutic dose of 1800-3600 mg/day in three divided doses. 8
- Initial dose: 100-300 mg at bedtime or 300 mg once daily 9, 8
- Day 1-3 titration: 300 mg on day 1,600 mg on day 2,900 mg on day 3 7
- Target therapeutic dose: 1800 mg/day (600 mg three times daily) is the minimum effective dose for most neuropathic pain conditions 8
- Maximum dose: 3600 mg/day (1200 mg three times daily) may be needed for optimal pain relief 8, 7
- Dosing frequency: Three times daily administration is mandatory due to saturable, nonlinear absorption pharmacokinetics 8
Special Population Dosing
Elderly or medically frail patients:
- Start at 100-200 mg/day with slower titration, increasing every 3-7 days or longer 8
- Lower doses may be effective due to age-related decline in renal function 8
- Mandatory renal function assessment before initiation 10
Renal impairment:
- Dose adjustment is mandatory as gabapentin is eliminated primarily by renal excretion 9, 8
- Dosing must be adjusted based on creatinine clearance values 9
Duration of Adequate Trial
- Minimum trial duration: 3-8 weeks for titration plus 2 weeks at maximum tolerated dose 8
- An adequate therapeutic trial may require 2 months or more, as efficacy develops gradually over several weeks 8
Administration Instructions
- Gabapentin can be taken with or without food 1
- If taking antacids containing aluminum and magnesium (Maalox®, Mylanta®, Gelusil®, Gaviscon®, Di-Gel®), wait at least 2 hours before taking the next dose of gabapentin 1
- If a tablet is broken in half, the unused half should be taken at the next scheduled dose; discard unused half-tablets after 28 days 1
- Never abruptly discontinue: Taper gradually over a minimum of 1 week to avoid withdrawal symptoms 8
Contraindications
Gabapentin is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. 1
Side Effects
Common Adverse Effects (Occur in >10% of patients)
- Dizziness (19%) 10, 6
- Somnolence/drowsiness (14%) 10, 6
- Lack of coordination 1
- Fatigue/feeling tired 1
- Gait disturbance (9%) 10
- Peripheral edema (7%) 6
- Nausea and vomiting 1
- Difficulty with speaking 1
- Tremor and jerky movements 1
- Double vision and unusual eye movements 1
Serious Adverse Effects
- Increased risk of suicidal thoughts or behavior: Like other antiepileptic drugs, gabapentin carries this risk 1
- Respiratory depression: Serious breathing problems can occur when combined with opioids, benzodiazepines, or other CNS depressants 1
- Neurologic toxicity: Particularly in patients with renal dysfunction due to drug accumulation 11
- Speech impairment: Can occur due to CNS effects, especially in elderly patients 10
- Increased fall risk: Due to dizziness, somnolence, and gait disturbance, particularly concerning in elderly patients 10
Adverse Event Withdrawal Rates
- Adverse event withdrawals occur in 11% of gabapentin-treated patients versus 8.2% with placebo 6
- Serious adverse events occur in 3.2% of gabapentin patients versus 2.8% with placebo 6
- At least one adverse event occurs in 63% of gabapentin patients versus 49% with placebo 6
Precautions and Warnings
Before Starting Gabapentin
Inform your healthcare provider if you have: 1
- Kidney problems or are on hemodialysis
- Depression, mood problems, or history of suicidal thoughts or behavior
- Diabetes
- Are pregnant, planning to become pregnant, or breastfeeding
During Treatment
- Do not drink alcohol or take other sedating medications without consulting your healthcare provider, as this may worsen sleepiness or dizziness 1
- Do not drive or operate heavy machinery until you know how gabapentin affects you, as it can slow thinking and motor skills 1
- Monitor for speech changes including slurred speech, reduced fluency, or changes in voice quality 10
- Watch for signs of suicidal thoughts or behavior, especially when starting treatment or changing doses 1
- Assess for fall risk, particularly in elderly patients experiencing dizziness or gait disturbance 10
Drug Interactions
- Gabapentin is not protein-bound, is not metabolized, and does not induce liver enzymes, minimizing drug interactions 2, 3
- However, caution is warranted when combining with other CNS-active medications 10
- Antacids containing aluminum and magnesium can affect gabapentin absorption 1
Efficacy Data
Postherpetic Neuralgia
- 32% of patients achieve substantial benefit (at least 50% pain relief) with gabapentin at 1200 mg daily or greater versus 17% with placebo (NNT 6.7) 6
- 46% achieve moderate benefit (at least 30% pain relief) versus 25% with placebo (NNT 4.8) 6
Painful Diabetic Neuropathy
- 38% achieve substantial benefit with gabapentin at 1200 mg daily or greater versus 21% with placebo (NNT 5.9) 6
- 52% achieve moderate benefit versus 37% with placebo (NNT 6.6) 6
Refractory Partial Seizures
- Gabapentin (600-1800 mg/day) reduces seizure frequency by ≥50% in 18-28% of patients with refractory partial seizures 3
- Overall seizure frequency decreases by 18-32% during 3-month treatment periods 3
Storage
Pregnancy and Breastfeeding
- Pregnancy: It is not known if gabapentin can harm an unborn baby; discuss risks and benefits with your healthcare provider 1
- Pregnant patients should consider enrolling in the North American Antiepileptic Drug (NAAED) Pregnancy Registry by calling 1-888-233-2334 1
- Breastfeeding: Gabapentin passes into breast milk; discuss feeding options with your healthcare provider 1
Critical Clinical Pearls
- Three times daily dosing is mandatory for standard gabapentin due to nonlinear, saturable absorption 8
- Efficacy develops gradually over several weeks; allow adequate trial duration before declaring treatment failure 8
- Start low and go slow in elderly patients to minimize fall risk from dizziness 8, 10
- Somnolence was reported by 80% of patients in HIV neuropathy trials at 2400 mg/day 4
- About 3-4 out of 10 patients achieve worthwhile pain relief, while over half will not have adequate response but may experience adverse events 6